Skip to content

Low Fat Diet for Fatigue in MS

A Randomized, Controlled Trial of Low-fat Diet for Fatigue in Multiple Sclerosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03322982
Enrollment
108
Registered
2017-10-26
Start date
2018-08-15
Completion date
2022-03-31
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

diet, low-fat

Brief summary

A randomized, controlled pilot trial of a dietary intervention vs. wait-list control in patients with MS and fatigue for management of their fatigue. The hypothesis of this study is that participants following the low-fat study diet will demonstrate a significant reduction in fatigue after four months compared to wait list controls.

Interventions

BEHAVIORALLow-fat diet

less than 20% calories from fat daily

Sponsors

National Multiple Sclerosis Society
CollaboratorOTHER
Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

Diet adherence assessments will be conducted by blinded assessors from OHSU bionutrition team.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

For participants with MS: Inclusion Criteria: * Age 18-70 * Diagnosis of MS by 2010 McDonald Criteria * EDSS ≤ 7.5 * Experiencing moderate to severe fatigue (MFIS ≥ 38)

Exclusion criteria

* Current cardiopulmonary disease requiring treatment * Diabetes * Pregnancy or breast-feeding * MS exacerbation within 30 days of screening visit * IV steroids within 30 days of screening visit * Dietary fat content of \<30% as assessed by food frequency questionnaire (FFQ) at screening visit * Fish oil or flax seed oil supplementation within 30 days of screening visit

Design outcomes

Primary

MeasureTime frameDescription
FatigueBaseline to month 4Measured by Modified Fatigue Impact Scale (MFIS). The MFIS is a 21-item questionnaire that assesses overall self-reported fatigue. Subjects rate agreement with a series of statements on a scale of 0 (rarely) to 4 (almost always), in context of their fatigue over the preceding four weeks. Total possible score of 84. Individuals with an MFIS score of \> 38 are considered to experience moderate to severe fatigue

Secondary

MeasureTime frameDescription
FatigueBaseline to month 4Measured by Fatigue Severity Scale (FSS). The FSS is a 9-item questionnaire, with subjects giving a response from 1-7 to indicate their degree of agreement with each statement.
DisabilityBaseline to month 4Measured by EDSS. The EDSS is an eight functional system scale including motor, sensory, cerebellar, brain stem, visual, mental, sphincteric, and other systems. Each functional system is graded from 0 (no disability) to 5 or 6 (maximal disability)20. An integrated score between 0 (normal examination) and 10 (death from MS) is formed based on the score in each functional system.

Other

MeasureTime frameDescription
Microbiome- Relative abundance of targeted species of gut microfloraBaseline to month 4Measured by 16S rRNA sequencing

Countries

United States

Contacts

Primary ContactAnna Orban
orban@ohsu.edu503-494-3549

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026